Zurich, Switzerland

Roland Martin

This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Martin. Retrieved from https://idiyas.com/inventor/roland-martin-9bk4cmyq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roland Martin: Innovator in Multiple Sclerosis Research

Introduction

Roland Martin is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical research, particularly in understanding multiple sclerosis. His innovative work has led to the development of valuable patents that aim to improve the lives of those affected by this condition.

Latest Patents

One of Roland Martin's notable patents is titled "Immunodominant Proteins and Fragments in Multiple Sclerosis." This patent focuses on identifying specific proteins that play a crucial role in the immune response related to multiple sclerosis. With 1 patent to his name, Martin's work is paving the way for new therapeutic approaches in treating this complex disease.

Career Highlights

Roland Martin is affiliated with Universität Zürich, where he conducts research and collaborates with other experts in the field. His dedication to advancing medical science has earned him recognition among his peers. His work not only contributes to academic knowledge but also has practical implications for patient care.

Collaborations

One of his notable collaborators is Mireia Sospedra Ramos. Together, they work on projects that explore the intricacies of multiple sclerosis and its treatment options. Their combined expertise enhances the quality and impact of their research.

Conclusion

In summary, Roland Martin is a key figure in the research of multiple sclerosis, with a focus on immunodominant proteins. His contributions through patents and collaborations are vital for advancing medical understanding and treatment of this challenging condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…